The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cystic Fibrosis Therapeutics-Global Market Insights and Sales Trends 2025
Synopsis
The global Cystic Fibrosis Therapeutics market size is expected to reach US$ 12680 million by 2029, growing at a CAGR of 13.5% from 2023 to 2029. The market is mainly driven by the significant applications of Cystic Fibrosis Therapeutics in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Cystic Fibrosis Therapeutics market. CFTR, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mucolytics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cystic Fibrosis Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cystic Fibrosis Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cystic Fibrosis Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cystic Fibrosis Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cystic Fibrosis Therapeutics covered in this report include Vertex Pharmaceuticals, F. Hoffmann-La Roche, AbbVie, Gilead Sciences, Novartis, AstraZeneca, Bayer, Celtaxsys and Pharmaxis, etc.
The global Cystic Fibrosis Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Vertex Pharmaceuticals
F. Hoffmann-La Roche
AbbVie
Gilead Sciences
Novartis
AstraZeneca
Bayer
Celtaxsys
Pharmaxis
ProQR Therapeutics
PTC Therapeutics
Alcresta Therapeutics
Insmed Incorporated
Savara
Cyclacel Pharmaceuticals
Vectura
Allergan
Global Cystic Fibrosis Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cystic Fibrosis Therapeutics market, Segment by Type:
CFTR
Mucolytics
PERT
Anti-infectives
Bronchodilators
Global Cystic Fibrosis Therapeutics market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cystic Fibrosis Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Cystic Fibrosis Therapeutics market size is expected to reach US$ 12680 million by 2029, growing at a CAGR of 13.5% from 2023 to 2029. The market is mainly driven by the significant applications of Cystic Fibrosis Therapeutics in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Cystic Fibrosis Therapeutics market. CFTR, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mucolytics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cystic Fibrosis Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cystic Fibrosis Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cystic Fibrosis Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cystic Fibrosis Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cystic Fibrosis Therapeutics covered in this report include Vertex Pharmaceuticals, F. Hoffmann-La Roche, AbbVie, Gilead Sciences, Novartis, AstraZeneca, Bayer, Celtaxsys and Pharmaxis, etc.
The global Cystic Fibrosis Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Vertex Pharmaceuticals
F. Hoffmann-La Roche
AbbVie
Gilead Sciences
Novartis
AstraZeneca
Bayer
Celtaxsys
Pharmaxis
ProQR Therapeutics
PTC Therapeutics
Alcresta Therapeutics
Insmed Incorporated
Savara
Cyclacel Pharmaceuticals
Vectura
Allergan
Global Cystic Fibrosis Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cystic Fibrosis Therapeutics market, Segment by Type:
CFTR
Mucolytics
PERT
Anti-infectives
Bronchodilators
Global Cystic Fibrosis Therapeutics market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cystic Fibrosis Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cystic Fibrosis Therapeutics
1.1 Cystic Fibrosis Therapeutics Market Overview
1.1.1 Cystic Fibrosis Therapeutics Product Scope
1.1.2 Cystic Fibrosis Therapeutics Market Status and Outlook
1.2 Global Cystic Fibrosis Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cystic Fibrosis Therapeutics Market Size by Region (2018-2029)
1.4 Global Cystic Fibrosis Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Cystic Fibrosis Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cystic Fibrosis Therapeutics Market Size (2018-2029)
1.6.1 North America Cystic Fibrosis Therapeutics Market Size (2018-2029)
1.6.2 Europe Cystic Fibrosis Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Cystic Fibrosis Therapeutics Market Size (2018-2029)
1.6.4 Latin America Cystic Fibrosis Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Cystic Fibrosis Therapeutics Market Size (2018-2029)
2 Cystic Fibrosis Therapeutics Market by Type
2.1 Introduction
2.1.1 CFTR
2.1.2 Mucolytics
2.1.3 PERT
2.1.4 Anti-infectives
2.1.5 Bronchodilators
2.2 Global Cystic Fibrosis Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cystic Fibrosis Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cystic Fibrosis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cystic Fibrosis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cystic Fibrosis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cystic Fibrosis Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cystic Fibrosis Therapeutics Revenue Breakdown by Type (2018-2029)
3 Cystic Fibrosis Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.2 Global Cystic Fibrosis Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cystic Fibrosis Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cystic Fibrosis Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cystic Fibrosis Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cystic Fibrosis Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cystic Fibrosis Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cystic Fibrosis Therapeutics Revenue Breakdown by Application (2018-2029)
4 Cystic Fibrosis Therapeutics Competition Analysis by Players
4.1 Global Cystic Fibrosis Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cystic Fibrosis Therapeutics as of 2022)
4.3 Date of Key Players Enter into Cystic Fibrosis Therapeutics Market
4.4 Global Top Players Cystic Fibrosis Therapeutics Headquarters and Area Served
4.5 Key Players Cystic Fibrosis Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Cystic Fibrosis Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Vertex Pharmaceuticals
5.1.1 Vertex Pharmaceuticals Profile
5.1.2 Vertex Pharmaceuticals Main Business
5.1.3 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Products, Services and Solutions
5.1.4 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Vertex Pharmaceuticals Recent Developments
5.2 F. Hoffmann-La Roche
5.2.1 F. Hoffmann-La Roche Profile
5.2.2 F. Hoffmann-La Roche Main Business
5.2.3 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Products, Services and Solutions
5.2.4 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 F. Hoffmann-La Roche Recent Developments
5.3 AbbVie
5.3.1 AbbVie Profile
5.3.2 AbbVie Main Business
5.3.3 AbbVie Cystic Fibrosis Therapeutics Products, Services and Solutions
5.3.4 AbbVie Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Gilead Sciences Recent Developments
5.4 Gilead Sciences
5.4.1 Gilead Sciences Profile
5.4.2 Gilead Sciences Main Business
5.4.3 Gilead Sciences Cystic Fibrosis Therapeutics Products, Services and Solutions
5.4.4 Gilead Sciences Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Gilead Sciences Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Cystic Fibrosis Therapeutics Products, Services and Solutions
5.5.4 Novartis Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 AstraZeneca
5.6.1 AstraZeneca Profile
5.6.2 AstraZeneca Main Business
5.6.3 AstraZeneca Cystic Fibrosis Therapeutics Products, Services and Solutions
5.6.4 AstraZeneca Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 AstraZeneca Recent Developments
5.7 Bayer
5.7.1 Bayer Profile
5.7.2 Bayer Main Business
5.7.3 Bayer Cystic Fibrosis Therapeutics Products, Services and Solutions
5.7.4 Bayer Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Bayer Recent Developments
5.8 Celtaxsys
5.8.1 Celtaxsys Profile
5.8.2 Celtaxsys Main Business
5.8.3 Celtaxsys Cystic Fibrosis Therapeutics Products, Services and Solutions
5.8.4 Celtaxsys Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Celtaxsys Recent Developments
5.9 Pharmaxis
5.9.1 Pharmaxis Profile
5.9.2 Pharmaxis Main Business
5.9.3 Pharmaxis Cystic Fibrosis Therapeutics Products, Services and Solutions
5.9.4 Pharmaxis Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Pharmaxis Recent Developments
5.10 ProQR Therapeutics
5.10.1 ProQR Therapeutics Profile
5.10.2 ProQR Therapeutics Main Business
5.10.3 ProQR Therapeutics Cystic Fibrosis Therapeutics Products, Services and Solutions
5.10.4 ProQR Therapeutics Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 ProQR Therapeutics Recent Developments
5.11 PTC Therapeutics
5.11.1 PTC Therapeutics Profile
5.11.2 PTC Therapeutics Main Business
5.11.3 PTC Therapeutics Cystic Fibrosis Therapeutics Products, Services and Solutions
5.11.4 PTC Therapeutics Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 PTC Therapeutics Recent Developments
5.12 Alcresta Therapeutics
5.12.1 Alcresta Therapeutics Profile
5.12.2 Alcresta Therapeutics Main Business
5.12.3 Alcresta Therapeutics Cystic Fibrosis Therapeutics Products, Services and Solutions
5.12.4 Alcresta Therapeutics Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 Alcresta Therapeutics Recent Developments
5.13 Insmed Incorporated
5.13.1 Insmed Incorporated Profile
5.13.2 Insmed Incorporated Main Business
5.13.3 Insmed Incorporated Cystic Fibrosis Therapeutics Products, Services and Solutions
5.13.4 Insmed Incorporated Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.13.5 Insmed Incorporated Recent Developments
5.14 Savara
5.14.1 Savara Profile
5.14.2 Savara Main Business
5.14.3 Savara Cystic Fibrosis Therapeutics Products, Services and Solutions
5.14.4 Savara Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.14.5 Savara Recent Developments
5.15 Cyclacel Pharmaceuticals
5.15.1 Cyclacel Pharmaceuticals Profile
5.15.2 Cyclacel Pharmaceuticals Main Business
5.15.3 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Products, Services and Solutions
5.15.4 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.15.5 Cyclacel Pharmaceuticals Recent Developments
5.16 Vectura
5.16.1 Vectura Profile
5.16.2 Vectura Main Business
5.16.3 Vectura Cystic Fibrosis Therapeutics Products, Services and Solutions
5.16.4 Vectura Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.16.5 Vectura Recent Developments
5.17 Allergan
5.17.1 Allergan Profile
5.17.2 Allergan Main Business
5.17.3 Allergan Cystic Fibrosis Therapeutics Products, Services and Solutions
5.17.4 Allergan Cystic Fibrosis Therapeutics Revenue (US$ Million) & (2018-2023)
5.17.5 Allergan Recent Developments
6 North America
6.1 North America Cystic Fibrosis Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cystic Fibrosis Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cystic Fibrosis Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cystic Fibrosis Therapeutics Market Dynamics
11.1 Cystic Fibrosis Therapeutics Industry Trends
11.2 Cystic Fibrosis Therapeutics Market Drivers
11.3 Cystic Fibrosis Therapeutics Market Challenges
11.4 Cystic Fibrosis Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
